| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/06/1997 | EP0787799A1 Staphylococcus aureus WCUH29 SpoIIIE Protein |
| 08/06/1997 | EP0787797A1 Human 5-HT1D receptor (serotonin receptor), process for preparing the same, its uses, antibodies directed against this receptor and transgenics expressing it |
| 08/06/1997 | EP0787796A1 Protective epitopes from adenylate cyclase-hemolysin(AC-Hly) and their use for treatment or prevention of Bordetella infections |
| 08/06/1997 | EP0787743A2 A3C6E2, a monoclonal antibody to the human stem cell factor (SCF)-receptor |
| 08/06/1997 | EP0787742A1 Anti-VEGF human monoclonal antibody |
| 08/06/1997 | EP0787741A1 Amylin isolated from pancreatic islet amyloid and pharmaceutical compositions comprising it |
| 08/06/1997 | EP0787502A2 A needle assembly |
| 08/06/1997 | EP0787499A1 Kininogen for promoting bone formation and inhibiting bone resorption |
| 08/06/1997 | EP0787498A2 Therapeutic human albumin having a low aluminium binding capacity |
| 08/06/1997 | EP0787497A2 Pharmaceutical preparation containing human growth hormone |
| 08/06/1997 | EP0787197A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 08/06/1997 | EP0787191A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens |
| 08/06/1997 | EP0787190A2 Hepatitis e virus antigens and uses therefor |
| 08/06/1997 | EP0787188A1 Chimeric receptors for the generation of selectively-activatable t h?-independent cytotoxic t cells |
| 08/06/1997 | EP0787187A1 Her4 human receptor tyrosine kinase |
| 08/06/1997 | EP0787185A2 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 08/06/1997 | EP0787184A1 Recombinant alternaria alternata allergens |
| 08/06/1997 | EP0787151A1 Monoclonal antibody fragments having immunosuppressant activity |
| 08/06/1997 | EP0787150A1 SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY |
| 08/06/1997 | EP0787149A1 POLYNUCLEOTIDE ENCODING C5a RECEPTOR |
| 08/06/1997 | EP0787148A1 Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| 08/06/1997 | EP0787147A1 Compositions and treatment for multiple sclerosis |
| 08/06/1997 | EP0787146A1 COMPOUNDS AND METHODS FOR INHIBITING $g(b)-PROTEIN FILAMENT FORMATION AND NEUROTOXICITY |
| 08/06/1997 | EP0787145A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/06/1997 | EP0787143A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 08/06/1997 | EP0787142A1 Neurturin and related growth factors |
| 08/06/1997 | EP0787138A1 Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 08/06/1997 | EP0787123A1 Inhibitors of farnesyl-protein transferase |
| 08/06/1997 | EP0787016A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase |
| 08/06/1997 | EP0787014A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 08/06/1997 | EP0787013A1 Human hypoxanthine-(guanine) phosphoribosyl transferase-2 |
| 08/06/1997 | EP0787012A1 Suppression of proteolytic activity by dysfunctional protease formation |
| 08/06/1997 | EP0787011A1 Pharmaceutical compositions |
| 08/06/1997 | EP0787010A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
| 08/06/1997 | EP0787009A1 Cancer inhibitory peptides |
| 08/06/1997 | EP0787008A1 Method for treating secondary immunodeficiency |
| 08/06/1997 | EP0786995A1 Use of receptor potentiators |
| 08/06/1997 | EP0786989A1 Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 08/06/1997 | EP0786987A1 Enterogenin pharmaceutical form |
| 08/06/1997 | EP0677107B1 Clotting inhibitor made from protostomia saliva |
| 08/06/1997 | EP0661995B1 Use of lectins for treatment of skin diseases |
| 08/06/1997 | EP0661989B1 Sustained-release protein formulations |
| 08/06/1997 | EP0585397B1 Bombesin analogs |
| 08/06/1997 | EP0585368B1 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 08/06/1997 | EP0548070B1 Monoclonal antibody for differentiation of squamous cell carcinoma antigens and method of use for same |
| 08/06/1997 | EP0502845B1 Human high-affinity neurotransmitter uptake system |
| 08/06/1997 | EP0479799B1 Wound healing |
| 08/06/1997 | EP0466688B1 Gap gene sequences and diagnostic uses thereof |
| 08/06/1997 | CN1156459A Trefoil peptide dimer |
| 08/06/1997 | CN1156174A Weierkang enzymatic (SOD) wine and its producing method |
| 08/05/1997 | US5654415 Antisense oligonucleotides to p53 |
| 08/05/1997 | US5654407 Human anti-TNF antibodies |
| 08/05/1997 | US5654405 Detection and purification of kgf; treating excessive epithelial cell growth; skin disorders, e.g., psoriasis; antitumor and carcinogenic agents |
| 08/05/1997 | US5654404 Molecule comprising first domain comprising hepatocyte growth factor, second domain comprising activin antagonist or transforming growth factor-beta antagonist |
| 08/05/1997 | US5654403 Immunoglobulins stabilized with a chelator of copper ions |
| 08/05/1997 | US5654400 Process for making peptide compounds having tachykinin antagonistic activity |
| 08/05/1997 | US5654399 Tetrapeptide derivative having antitumor activity |
| 08/05/1997 | US5654398 A polypeptide of <31 amino acids with a stabilized electronic configuration to bind to the iib site of rev-responsive element of mrna and having a greater affinity than that of the wild-type rev protein |
| 08/05/1997 | US5654334 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester |
| 08/05/1997 | US5654333 Methods for prevention of cancer using phenylacetic acids and derivatives thereof |
| 08/05/1997 | US5654313 Administering a prolactin-inhibiting compound and subsequently a prolactin-stimulating compound |
| 08/05/1997 | US5654301 Amino acid derivative anticonvulsant |
| 08/05/1997 | US5654294 Spiro lactam dual action inhibitors |
| 08/05/1997 | US5654290 Anticoagulant; antitumor agents; absorption by brain tissue |
| 08/05/1997 | US5654282 Antiinflammatory agents; viricides; anticancer agents |
| 08/05/1997 | US5654279 Tissue destruction in cryosurgery by use of thermal hysteresis |
| 08/05/1997 | US5654278 Composition and method comprising growth hormone and leucine |
| 08/05/1997 | US5654277 Inhibiting tumor metastasis in mammals by administering specific tetra- or pentapeptides |
| 08/05/1997 | US5654276 Peptides and compounds that bind to the IL-5 receptor |
| 08/05/1997 | US5654274 Inhibit growth of target cells, viruses or virally-infected cells |
| 08/05/1997 | US5654273 Synducin mediated modulation of tissue repair |
| 08/05/1997 | US5654272 Including an amino acid sequence of cysteine-(amino acid)-cysteine to complex the isotope and a target binding sequencefor target sites including atherosclerotic plaque and alzheimer's amyloid plaque; scintigraphy |
| 08/05/1997 | US5654271 Fungicidally active compounds |
| 08/05/1997 | US5654270 Use of fibromodulin to prevent or reduce dermal scarring |
| 08/05/1997 | US5654267 Wound healing agent |
| 08/05/1997 | US5654182 Site-specific integration or disassembly of nucleic acid sequences within the genome of a mammilian host cell for the activation or inactivation of a functional expression unit; lineage analysis of tissues |
| 08/05/1997 | US5654174 Herpes simplex virus glycoprotein D variants |
| 08/05/1997 | US5654173 Secreted proteins and polynucleotides encoding them |
| 08/05/1997 | US5654172 Gabaa receptor epsilon subunit |
| 08/05/1997 | US5654171 Cosmetics; skin disorders |
| 08/05/1997 | US5654170 Polycystic kidney disease gene |
| 08/05/1997 | US5654167 Antimicrobial proteins, compositions containing same and uses thereof |
| 08/05/1997 | US5654157 Genetic engineering |
| 08/05/1997 | US5654151 High affinity HIV Nucleocapsid nucleic acid ligands |
| 08/05/1997 | US5654147 Method of hybridization using oligonucleotide probes |
| 08/05/1997 | US5654145 Trophinin and trophinin-assisting nucleic acids and methods of detection thereof |
| 08/05/1997 | US5654140 Diagnosis of colorectal and breast cancer |
| 08/05/1997 | US5654019 Bone enhancing factors from whey and compositions containing the same |
| 08/05/1997 | US5654010 Composition for sustained release of human growth hormone |
| 08/05/1997 | US5654007 Friable, spherically aggregated particles of powdered drug; free-flowing, respiratory inhalants |
| 08/05/1997 | US5653987 Liquid formulations for proteinic pharmaceuticals |
| 08/05/1997 | US5653986 Vaccine aganinst cholera |
| 08/05/1997 | US5653984 Extract of periwinkle seed and compositions containing the same |
| 08/05/1997 | US5653979 Immunotargeting of plasminogen activators to the pulmonary endothelium |
| 08/05/1997 | US5653978 Human anti-Rh(D) monoclonal antibodies and methods of use of antibodies in immunotherapy |
| 08/05/1997 | US5653975 Implanting encapsulated cells capable of producing human growth factor or trophic factor for diffusion into the central nervous system; treatment of diabetes; anemia; hypoparathyroidism; parkinson's and alzheimer's disease |
| 08/05/1997 | US5653974 High cytolytic acitivity |
| 08/05/1997 | US5653964 Dentinal desensitizing compositions |
| 08/05/1997 | CA2049119C Lipoprotein removal by soluble enzymes |
| 08/05/1997 | CA1339211C Plasminogen activator and thrombolytic agent |